ALLIAR (AALR3) Main Indicators
Basic Data - AALR3
Company | ALLIAR |
Corporate Name | ALLIANÇA SAÚDE E PARTICIPAÇÕES S.A. |
Registration Status | ATIVO |
Issuer Status | FASE OPERACIONAL |
Listing Segment | Novo Mercado |
Activity | Prestação de serviços de medicina diagnóstica |
Share | AALR3 |
Quote Date | 09/18/2024 |
Share Type | ON |
Last Closing | R$ 15.30 |
Quotation Factor | 1 Share |
Financial Volume | R$ 489.64 thousand |
Last Statement | ITR - 06/30/2024 |
Sector | Saúde |
Subsector | Serv.Méd.Hospit..Análises e Diagnósticos |
Segment | Serv.Méd.Hospit..Análises e Diagnósticos |
Participation Indexes | IGC, IGNM, ITAG |
Updated 09/19/2024 |
Relative Prices - AALR3
Price/Earnings | -8.29 |
Price/SBV | 1.66 |
Price/Net Sales | 1.52 |
Price/CFO | 10.82 |
Price/FCF | 21.01 |
Price/Total Assets | 0.67 |
Price/EBIT | 46.32 |
Price/Working Capital | -11.64 |
Price/NCAV | -1.03 |
EV/EBIT | 61.33 |
EV/EBITDA | 16.13 |
EV/Net Sales | 2.02 |
EV/CFO | 14.33 |
EV/FCF | 27.82 |
EV/Total Assets | 0.89 |
Company Market Cap | R$ 1.81 B |
Enterprise Value | R$ 2.40 B |
Current Financial Statement Date | 06/30/2024 |
Current Share Price | R$ 15.30 |
Share Price Date | 09/18/2024 |
Dividend Yield | 0.00% |
Updated 09/19/2024 |
Income Statement - AALR3
Net Revenue | R$ 1.19 B |
Gross Result | R$ 354.27 M |
EBIT | R$ 39.07 M |
Depreciation and Amortization | - R$ 109.55 M |
EBITDA | R$ 148.62 M |
Net Profit | - R$ 218.43 M |
Net Profit/Share | - R$ 1.85 |
Updated 08/09/2024 |
Net Revenue | R$ 317.74 M |
Gross Result | R$ 98.16 M |
EBIT | R$ 43.92 M |
Depreciation and Amortization | - R$ 26.60 M |
EBITDA | R$ 70.51 M |
Net Profit | R$ 433.00 thousand |
Profit/Share | R$ 0.00 |
Updated 08/09/2024 |
Price and Volume Behavior - AALR3
Lowest Price 52 weeks | R$ 6.19 |
Highest Price 52 weeks | R$ 17.07 |
Variation 2024 | 80.00% |
Variation 1 year | 64.69% |
Variation 2 years(total) | -25.22% |
Variation 2 years(yearly) | -13.47% |
Variation 3 years(total) | 26.45% |
Variation 3 years(yearly) | 8.12% |
Variation 4 years(total) | 37.34% |
Variation 4 years(yearly) | 8.25% |
Variation 5 years(total) | -18.72% |
Variation 5 years(yearly) | -4.06% |
Average Daily Volume (3 months) | R$ 683.72 thousand |
Updated 09/19/2024 |
Returns and Margins - AALR3
Return on Initial Tangible Capital | 2.29% |
Return on Initial Invested Capital | 1.46% |
Pre-Tax Return on Initial Tangible Capital | 3.46% |
Pre-Tax Return on Initial Invested Capital | 2.22% |
Return on Initial Shareholder´s Equity | -25.24% |
Return on Initial Asset | -8.66% |
Gross Margin | 29.80% |
Net Margin | -18.37% |
EBIT Margin | 3.29% |
EBITDA Margin | 12.50% |
Initial Asset Turnover | 0.47 |
Financial Leverage | 2.47 |
Liabilities/Net Worth | 1.47 |
Net Debt/EBITDA | 3.95 |
Updated 08/09/2024 |
Balance Sheet - AALR3
Cash and Cash Equivalents | R$ 254.48 M |
Total Assets | R$ 2.69 B |
Short-Term Debt | R$ 273.79 M |
Long-Term Debt | R$ 567.38 M |
Gross Debt | R$ 841.17 M |
Net Debt | R$ 586.69 M |
Shareholder´s Equity | R$ 1.09 B |
Share Book Value | R$ 9.21 |
Common Shares | 118,292,816 |
Preferred Shares | 0 |
Total | 118,292,816 |
Common Shares in Treasury | 90,827 |
Preferred Shares in Treasury | 0 |
Total in Treasury | 90,827 |
Common Shares (Except Treasury) | 118,201,989 |
Preferred Shares (Except Treasury) | 0 |
Total (Except Treasury) | 118,201,989 |
Updated 08/09/2024 |
Cash Flow - AALR3
Operating Cash Flow | R$ 167.23 M |
Cash Flow from Investments | - R$ 102.89 M |
Financing Cash Flow | R$ 94.62 M |
Increase (Reduction) in Cash and Equivalents | R$ 158.96 M |
Updated 08/09/2024 |
Operating Cash Flow | R$ 142.64 M |
Cash Flow from Investments | - R$ 32.60 M |
Financing Cash Flow | R$ 46.66 M |
Increase (Reduction) in Cash and Equivalents | R$ 156.69 M |
Updated 08/09/2024 |
Experimental - AALR3
CAPEX 3 months | - R$ 23.95 M |
Free Cash Flow 3 months | R$ 118.68 M |
CAPEX 12 months | - R$ 81.08 M |
Free Cash Flow 12 months | R$ 86.15 M |
Updated 08/09/2024 |